Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Koji Ando, Ankur K. Shah, Vibhu Sachdev, Benjamin P. Kleinstiver, Julian Taylor-Parker, Moira M. Welch, Yiheng Hu, Ravi Salgia, Forest M. White, Jeffrey D. Parvin, Al Ozonoff, Lucia E. Rameh, J. Keith Joung, Ajit K. Bharti
Published Mar 18, 2017 · Vol. 8, No. 27 · pp. 43733-43751
Ravyn M. Thompson, Dominik Dytfeld, Leticia Reyes, Reeder M. Robinson, Brittany Smith, Yefim Manevich, Andrzej Jakubowiak, Mieczyslaw Komarnicki, Anna Przybylowicz-Chalecka, Tomasz Szczepaniak, Amit K. Mitra, Brian G. Van Ness, Magdalena Luczak, Nathan G. Dolloff
Published Mar 16, 2017 · Vol. 8, No. 22 · pp. 35863-35876
Erik N. Taylor, Yao Ding, Shan Zhu, Eric Cheah, Phillip Alexander, Leon Lin, George E. Aninwene II, Matthew P. Hoffman, Anita Mahajan, Abdallah S.R. Mohamed, Nathan McDannold, Clifton D. Fuller, Clark C. Chen, Richard J. Gilbert
Published Mar 16, 2017 · Vol. 8, No. 26 · pp. 41815-41826